Miller Firm to Be Lead Trial Attorneys in First Monsanto Trial, France to Ban Roundup

The first trial addressing the carcinogenic properties of Monsanto’s Roundup® weed killer will begin June 18, 2018, in the Superior Court for the County of San Francisco. The Miller Firm will be the lead trial attorneys. The Miller Firm is also presently accepting new clients who developed non-Hodgkin’s Lymphoma after exposure to Roundup®. If this has happened to you, please visit the Roundup Lawsuit page to request a free consultation.

The plaintiff in this trial is DeWayne Johnson, a former groundskeeper for the Benicia Unified School District. As of 2014, Mr. Johnson’s job had already entailed the mixing and spraying of hundreds of gallons of Monsanto’s glyphosate-containing products onto school properties for several years. He began to experience a severe skin irritation and rash over the summer, which he reported to his health care providers. Medical notes from this era show the condition seemed to worsen with exposure to Monsanto’s RangerPro®. His health care providers explored Monsanto’s Material Safety Data Sheet for the product online, which did not mention any type of cancer risk.

Sadly, in August of 2014, Mr. Johnson was diagnosed with epidermotropic T-cell lymphoma. His work still required him to apply and be in close contact with glyphosate products. He suffered an extensive dermal exposure to the chemicals in Jan. 2015. Though Mr. Johnson underwent chemotherapy throughout the year, his disease progressed and in September, a biopsy revealed mycosis fungoides, which is a non-Hodgkin’s lymphoma, with large cell transformation – a major and devastating advancement of his illness.

The Miller Firm is also co-lead counsel in the consolidated litigation against Monsanto on behalf of victims like Mr. Johnson, who have developed non-Hodgkin’s lymphoma in the United States.

France to Vote Against the Authorization of Roundup®

France will vote against renewing the European license for the weed killer glyphosate. This decision highlights the uncertain future of the use of Monsanto’s Roundup® in the European Union, where a relicensing decision has been delayed. In 2015, the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) classified glyphosate as a “probable human carcinogen” after an extensive study of peer-reviewed science. Related Scientific panels, a Hague tribunal, and investigations by U.S. & European lawmakers have ensued to address glyphosate’s serious health risks.

A vote on the possible license renewal is due Oct. 4, requiring a majority of member states. While France and Germany have abstained from previous votes, “France will vote against the reauthorization of glyphosate due to the doubts that remain about its dangerousness,” a ministry official said, according to Reuters (reuters.com).

If you developed non-Hodgkin’s Lymphoma after exposure to Roundup®, please visit our Roundup Lawsuit page or call the Miller Firm at 1-800-882-2525.